Rate My Professor Jane Harding

Professor Harding's research centres on fetal and newborn physiology, with a focus on neonatal glycaemia, nutrition, and long-term neurodevelopmental outcomes for at-risk infants, including those born preterm or hypoglycaemic. Her team pioneered the use of oral dextrose gel to treat and prevent neonatal hypoglycaemia, influencing global clinical guidelines. She has authored over 415 publications, cited more than 20,000 times, including key works such as 'Oral dextrose gel to prevent hypoglycaemia in at-risk neonates' (Cochrane Database Syst Rev, 2023), 'Evaluation of oral dextrose gel for prevention of neonatal hypoglycaemia in babies at risk' (PLoS Med, 2021), and 'Neonatal hypoglycaemia' (BMJ Med, 2024). Her contributions have earned prestigious honours, including Fellow of the Royal Society Te Apārangi (2001), Officer of the New Zealand Order of Merit (2002), Health Research Council Beaven Medal (2016), Rutherford Medal (2019), Dame Companion of the New Zealand Order of Merit (2020), and the Prime Minister's Science Prize (2022) with her neonatal glucose studies team. This work has transformed management practices, improving lifelong health outcomes for mothers and babies worldwide.